EASY BIO,Inc. (353810.KQ)
KRW 4570.0
(0.44%)
KRW 4570.0
(0.44%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | 33.68 Billion | -8.12 Billion | 14.06 Billion | 16.46 Billion |
| Net Income | 15.54 Billion | 9.34 Billion | 10.84 Billion | 10.42 Billion |
| Depreciation & Amortization | 3.57 Billion | 3.76 Billion | 2.8 Billion | 1.69 Billion |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | - | - | - | - |
| Change in working capital | 15.23 Billion | -22.15 Billion | -69.14 Million | 1.08 Billion |
| Other non-cash items | -10.45 Billion | 925.24 Million | 492.28 Million | 3.26 Billion |
| Investing Cash Flow | -41.34 Billion | 513.76 Million | -20.06 Billion | -525.45 Million |
| Investments in PPE | -1.96 Billion | -2.04 Billion | -1.83 Billion | -1.21 Billion |
| Acquisitions | 10.31 Million | 2.27 Million | -14.98 Billion | 1.71 Million |
| Investment purchases | -52.6 Billion | -6.48 Billion | -16.53 Billion | -1.04 Billion |
| Sales/Maturities of investments | 13.21 Billion | 9.04 Billion | 13.29 Billion | 1.73 Billion |
| Other Investing Activities | 10.00 | -17.00 | 8.79 Million | 816.1 Million |
| Financing Cash Flow | -3.4 Billion | 27.87 Billion | 6.22 Billion | -433.03 Million |
| Debt repayment | -78.6 Million | -59.92 Billion | -37.12 Billion | -51.87 Billion |
| Dividends payments | -2.62 Billion | -2.56 Billion | -2.56 Billion | - |
| Common Stock Repurchased | - | - | - | -165.98 Million |
| Common Stock Issuance | - | - | - | -17 Million |
| Other Financing Activities | -10.00 | 90.35 Billion | 45.91 Billion | 103.26 Billion |
| Accounts receivables | 13.93 Billion | -19.5 Billion | 5.57 Billion | 1.25 Billion |
| Accounts payables | -23.5 Million | 1.9 Billion | -1.84 Billion | 718.24 Million |
| Inventory | 3.03 Billion | -4.87 Billion | -2.2 Billion | -641.57 Million |
| Other working capital | -1.71 Billion | 309.76 Million | -1.59 Billion | -247.54 Million |
| Cash at beginning of period | 39.91 Billion | 20.7 Billion | 20.44 Billion | 4.94 Billion |
| Cash at end of period | 29.06 Billion | 39.91 Billion | 20.7 Billion | 20.44 Billion |
| Capital Expenditure | -1.96 Billion | -2.04 Billion | -1.83 Billion | -1.21 Billion |
| Effect of forex changes on cash | 220.04 Million | -1.05 Billion | 20.38 Million | -7.58 Million |
| Net cash flow / Change in cash | -10.84 Billion | 19.2 Billion | 255.3 Million | 15.49 Billion |
| Free Cash Flow | 31.71 Billion | -10.17 Billion | 12.22 Billion | 15.24 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.34 Billion | 4.68 Billion | 15.54 Billion | 4.73 Billion | 3.65 Billion | 3.51 Billion |
| Depreciation & Amortization | 1.31 Billion | 1.08 Billion | 3.57 Billion | 926.1 Million | 918.13 Million | 917.73 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -5.76 Billion | -271.05 Million | 15.23 Billion | 32.06 Billion | -15.77 Billion | 9.96 Billion |
| Other non-cash items | 1.06 Billion | 2.47 Billion | -10.45 Billion | -29.56 Billion | -71.95 Million | -13.26 Million |
| Investing Cash Flow | -57.46 Billion | -55.57 Billion | -41.34 Billion | -27.02 Billion | -478.8 Million | -5.6 Billion |
| Investments in PPE | -1.17 Billion | -1.86 Billion | -1.96 Billion | -1.26 Billion | -213.06 Million | -121.59 Million |
| Acquisitions | -87.5 Billion | 5.79 Million | 10.31 Million | 2.8 Million | 1.46 Million | 1.37 Million |
| Investment purchases | 29.38 Billion | -89.74 Billion | -52.6 Billion | -50.45 Billion | -1.65 Billion | -8.64 Billion |
| Sales/Maturities of investments | -4.2 Million | 3.76 Billion | 13.21 Billion | 12.3 Billion | 1.39 Billion | 3.15 Billion |
| Other Investing Activities | -56.28 Billion | 32.27 Billion | 10.00 | 12.38 Billion | -3.00 | 3.14 Billion |
| Financing Cash Flow | 73.43 Billion | 44.44 Billion | -3.4 Billion | -13.34 Billion | 17.22 Billion | -15.16 Billion |
| Debt repayment | -60.65 Billion | -43.95 Billion | -78.6 Million | -13.07 Billion | -20.98 Billion | -55.41 Billion |
| Dividends payments | -3.41 Billion | - | -2.62 Billion | -65.69 Million | - | -2.56 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 16.2 Billion | 664.65 Million | -10.00 | 657.39 Million | 38.21 Billion | 42.8 Billion |
| Accounts receivables | 1.41 Billion | -1.55 Billion | 13.93 Billion | 29.44 Billion | -18.32 Billion | 11.65 Billion |
| Accounts payables | 188.38 Million | -1.87 Billion | -23.5 Million | 1.98 Billion | 415.61 Million | -606.94 Million |
| Inventory | 1.07 Billion | 2.63 Billion | 3.03 Billion | -175.54 Million | 2.72 Billion | -255.84 Million |
| Other working capital | -8.25 Billion | 531.98 Million | -1.71 Billion | 811.83 Million | -585.25 Million | -823.89 Million |
| Cash at beginning of period | 29.99 Billion | 29.06 Billion | 39.91 Billion | 31.94 Billion | 26.44 Billion | 33.07 Billion |
| Cash at end of period | 46.36 Billion | 29.99 Billion | 29.06 Billion | 29.06 Billion | 31.94 Billion | 26.44 Billion |
| Capital Expenditure | -1.17 Billion | -1.86 Billion | -1.96 Billion | -1.26 Billion | -213.06 Million | -121.59 Million |
| Effect of forex changes on cash | -559.7 Million | 931.94 Million | 220.04 Million | -78.67 Million | 26.61 Million | -254.63 Million |
| Net cash flow / Change in cash | 16.37 Billion | 925.74 Million | -10.84 Billion | -2.87 Billion | 5.5 Billion | -6.63 Billion |
| Free Cash Flow | -212.51 Million | 3.12 Billion | 31.71 Billion | 36.3 Billion | -11.48 Billion | 14.26 Billion |
BAZA3
LCTX
ALSE
ESYJY
IVA
0IFJ